GE Announces Pricing of Offerings of $8.25 Billion Senior Notes issued by GE HealthCare

BOSTON – November 9, 2022 –  General Electric Company (“GE”) (NYSE: GE) announced today that GE Healthcare Holding LLC (“GE HealthCare”), a direct, wholly-owned subsidiary of GE, priced an offering of $1,000,000,000 aggregate principal amount of 5.550% senior notes due 2024 (the “2024 notes”), $1,500,000,000 aggregate principal amount of 5.600% senior notes due 2025 (the... Read more

Meet Dragonfly 600, Oxford Instruments’ New Flagship Confocal Microscope

Oxford Instruments Andor, a world leader in scientific imaging solutions, has today announced the launch of Dragonfly 600, further strengthening its award-winning confocal microscopy portfolio.  Dragonfly 600 introduces three ground-breaking features; a new total internal reflection fluorescence (TIRF) modality: Borealis TIRF (B-TIRF), a high-power laser engine, and a unique design of 3D Super-Resolution module which... Read more

Daicel Chiral Technologies Announces the Launch of CHIRALPAK® IM

November 8, 2022 For Immediate Release Daicel Chiral Technologies Announces the Launch of CHIRALPAK® IM West Chester, PA (November 1, 2022) – Daicel Chiral Technologies introduces CHIRALPAK® IM. This new selector Cellulose 3 chloro 4 methyl phenyl carbamate is the immobilized version of CHIRALCEL® OZ. This cellulose-based immobilized chiral selector is designed for HPLC and SFC to improve the... Read more

Bruker Announces Acquisition of Inscopix for Neuroscience Research

Head-Mounted Miniscopes Expand Neural Functional Imaging Capabilities MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Inscopix, Inc., a neuroscience pioneer and market leader of miniaturized microscopes, known as miniscopes, for freely moving animal brain imaging. Since its founding in 2011, Inscopix’s flagship miniscope systems have been deployed in over 600... Read more

Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2022 Jefferies London Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer will present and participate in an analyst moderated question and answer session on behalf of the Company on Tuesday, November 15, 2022 at 12:00 PM Eastern Time.... Read more